| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.28 | 2e-07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |